Clin Mol Hepatol.
2022 Apr;28(2):269-272. 10.3350/cmh.2022.0040.
Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphs
- Takamura S
1 - Teraki Y1
- Katayama E2
- Kawaguchi T3
- Kawaguchi M3
- Nakano D3
- Tsutsumi T3
- Nagoshi S4
- Nakama T2
- Torimura T3
- Affiliations
-
- 1Department of Dermatology, Saitama Medical Center, Saitama Medical University, Saitama, Japan
- 2Department of Dermatology, Kurume University School of Medicine, Kurume, Japan
- 3Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan
- 4Department of Gastroenterology and Hepatology, Saitama Medical Center, Saitama Medical University, Saitama, Japan
- KMID: 2528257
- DOI: http://doi.org/10.3350/cmh.2022.0040
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease
- Hepatic Fibrosis and Cancer: The Silent Threats of Metabolic Syndrome
- Diagnostic Performance of Hepatic Steatosis Algorithms in Korean Population with Metabolic-Associated Fatty Liver Disease
- Approach to Fatty Liver Disease in Patients with Type 2 Diabetes
- Noninvasive diagnosis of pediatric nonalcoholic fatty liver disease
